Zaloguj Zarejestruj się zadarmo

Alkermes plc organizacji Przewidiwany EPS Q/Q

Jaka jest wartość Przewidiwany EPS Q/Q organizacji Alkermes plc?

Wartość Przewidiwany EPS Q/Q organizacji Alkermes plc to -82.61%

Jaka jest definicja Przewidiwany EPS Q/Q?



Perspektywiczna kwartalna stopa wzrostu z roka (Estimated quarterly EPS growth rate) rok do roku, to szacowany wzrost wartości EPS spółki na następny kwartał w porównaniu do wyników z poprzedniego kwartału.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Przewidiwany EPS Q/Q firm w Health Care sektor na NASDAQ w porównaniu do Alkermes plc

Czym się zajmuję organizacja Alkermes plc?

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

Firmy z przewidiwany eps q/q podobne do Alkermes plc